Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

Clicks: 547
ID: 114673
1997
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #3 of 86 articles by views in Vaccine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The safety and immunogenicity of purified fusion protein (PFP-2) respiratory syncytial virus (RSV) vaccine was evaluated in an open label study in 37 frail institutionalized persons over age 65. Vaccination was well tolerated without significant side-effects. Thirty-six of 37 volunteers completed th …
Reference Key
ar1997vaccinesafety Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Falsey AR, Walsh EE
Are you one of these authors? Claim your profile
Journal Vaccine
Year 1997
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9269057
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine safety research support non-u.s. gov't female male aged 80 and over Antibodies viral / blood neutralization tests respiratory syncytial virus infections / immunology respiratory syncytial virus infections / prevention & control* viral fusion proteins / immunology vaccines immunoglobulin g / blood chronic disease human / immunology* respiratory syncytial virus viral vaccines / adverse effects respiratory tract infections / immunology a r falsey e e walsh pmid:9269057 doi:10.1016/s0264-410x(97)00002-9 homes for the aged nursing homes respiratory tract infections / prevention & control* synthetic / pharmacology* viral vaccines / pharmacology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.